Our data shows that ISO pretreatment can downregulate NLRP3, caspase-1, and IL-1β mRNA and protein levels in the retina after ischemic stroke, suggesting that the protective mechanisms underlying ISO pretreatment may be related to the direct inhibition of retinal NLRP3 inflammasome activation. Here, NLRP3 is linked to ischemic stroke.